相关实验视频

Updated: Jun 10, 2025

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

32.2K

针对阿尔茨海默病病理学的领先血液测试的对比比较

Suzanne E Schindler1, Kellen K Petersen1, Benjamin Saef1

  • 1Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|October 12, 2024
PubMed
概括

新的阿尔茨海默病 (AD) 血液测试显示出有前途. 血p-tau217测量表明,在分类粉样蛋白病理和其他AD相关结果方面,其准确度最高,改善了诊断潜力.

关键词:
A/T/N/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/N/A/T/A/T/N/A/T/A/T/N/A/T/N/A/T/T/A/T/T/T/A/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T/T氨基化物 氨基化物生物标志物 生物标志物血液 血液 血液 血液 血液状纤维化酸性蛋白质是状纤维化的.神经纤维光的光源是神经纤维光.血等离子体是什么?在p-tau.知道的 知道的 知道的

更多相关视频

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

3.7K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

17.3K

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
166